At last! The cure for the leprous disease of smoking is nearly upon us.
Almost 6 years ago we discussed a vaccine to help people quit smoking as it entered human clinical trials. Now it looks like the finishing touches have been put on a deal that will go into effect once phase III testing of the drug now called NicVAX is completed.
Move over suicide-inducing Champix, there's a new money-maker in town.
Did I say money-maker? I think I did.
Others have fallen short of this goal, in pursuit of a smoking-cessation market expected to hit $4.6 billion worldwide by 2016.
Fortunately for those who enjoy smoking and choose to exercise their free will in this fair country of ours, no doubt the vaccine will be entirely voluntary.
Well, at least until the government make it compulsory for those seeking treatment on the NHS, anyway.